Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-02-05 00:00:00 ET · period of report 2026-02-05 · accession 0001231589-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-02-05 | 2026-02-05 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $483.24 | -8,300 | 36.8K | -18% | -$4.01M |
| DT | 2026-02-05 | 2026-02-05 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DT | 2026-02-05 | 2026-02-05 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 50.1K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-05 | S | D | 934 | $484.92 | 37,456 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $484.32 to $485.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-02-05 | S | D | 1,103 | $482.57 | 41,138 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $482.29 to $483.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-02-05 | S | D | 2,363 | $481.93 | 42,241 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $481.29 to $482.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-02-05 | S | D | 477 | $480.92 | 44,604 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $480.21 to $481.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-02-05 | S | D | 2,748 | $483.92 | 38,390 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $483.32 to $484.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-02-05 | S | D | 675 | $485.52 | 36,781 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $485.34 to $485.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-02-05 | M | A | 8,300 | $146.03 | 45,081 | D | — | — | |
| 8 | Derivative | Stock Option | 2026-02-05 | M | D | 8,300 | $0.00 | 50,100 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock |